PMAIP1 and cancer: For example, proteasome-mediated degradation of NOXA is enhanced in chemotherapeutic-resistant cancer cells [15] and histone deacetylase (HDAC) inhibitors can reactivate epigenetically silenced NOXA gene expression, which results in the induction of apoptosis [16,17].